Core Framework & Diagram How Does Infection Influence Cancer Risk?
July 14, 20261 Min Read Why Does Cancer Risk Rise With Age?
July 14, 2026One in every five cancer patients globally was 'pushed in' by infection
—— This isn't a metaphor — it's a WHO statistic.
I. A Nobel Prize that changed how we understand cancer
In 2008, German virologist Harald zur Hausen won the Nobel Prize in Physiology or Medicine for discovering that human papillomavirus (HPV) causes cervical cancer. This finding was revolutionary at the time. In the 1970s, cancer was generally viewed as 'a disease of gene mutation' — no one believed a sexually transmitted virus directly caused cancer. Zur Hausen persisted in research for twenty years, finally isolating HPV DNA in cervical cancer cells and proving a causal relationship between virus and cancer. This discovery directly catalyzed the HPV vaccine — today, a single vaccine can prevent approximately ninety percent of cervical cancers, the first truly meaningful 'cancer prevention vaccine' in human history.
2. Channel one: viruses directly rewrite your cellular instructions
HPV high-risk types (primarily types 16 and 18) infect cervical epithelial cells and inject two key viral proteins into cells: E6 protein degrades p53 — the cell's most important 'gatekeeper,' commanding cells to stop dividing or initiate apoptosis when DNA is damaged. E6 eliminates p53, so damaged cells continue dividing uncontrolled. E7 protein inactivates Rb protein (retinoblastoma protein) — Rb is the cell cycle brake; E7 disables this brake, putting the cell into continuous proliferation.
With both 'gatekeepers' simultaneously removed, cells rapidly slide toward cancer. From HPV infection to cervical cancer typically takes ten to fifteen years. This lengthy process provides ample intervention windows for regular cervical smear screening — which is also why cervical cancer has the best prognosis among common female cancers: detect early, and it's nearly one hundred percent curable.
HBV's mechanism is similar — HBV X protein likewise interferes with p53 function and activates multiple pro-cancer signaling pathways. Approximately fifty percent of hepatocellular carcinoma globally is directly associated with HBV infection; the proportion is higher in the Asia-Pacific region.
3. Channel two: inflammation is cancer's 'greenhouse'
pylori infection of gastric mucosa causes persistent chronic inflammation, activating neutrophils and macrophages to massively secrete reactive oxygen species (ROS) and reactive nitrogen species (RNS). These highly reactive molecules continuously bombard surrounding cells' DNA like randomly fired bullets, allowing damage to continuously accumulate. Under chronic inflammatory conditions, the damage rate exceeds repair capacity and mutations begin building up.
Simultaneously, inflammatory factors (IL-6, TNF-α) activate NF-κB — the transcription factor connecting inflammation and cancer. NF-κB is the core 'switch' linking inflammation to cancer, simultaneously promoting cell proliferation, suppressing cell apoptosis, promoting tumor angiogenesis, and helping cancer cells invade surrounding tissue. Chronic inflammation isn't cancer, but it provides cancer with the most favorable growth conditions: continuous DNA damage, anti-apoptosis signals, and abundant blood vessel supply.
NF-κB's discovery provides a molecular-level theoretical basis for anti-inflammatory therapy preventing cancer — also one mechanism by which long-term aspirin use may reduce certain cancer risks, though clinical application still requires careful weighing of risks and benefits.
4. Channel three: immune suppression — when cancer's 'hunters' malfunction
HIV directly infects CD4+ T cells — the core of the entire immune coordination system. As CD4+ T cell counts fall, multiple cancer risks skyrocket: Kaposi's sarcoma risk rises 3,640-fold, non-Hodgkin's lymphoma 77-fold, anal cancer approximately 45-fold, cervical cancer approximately 5-fold. These numbers directly reveal the central role of immune surveillance in cancer defense. Normal people produce potentially cancerous cells daily, but NK cells and cytotoxic T cells continuously patrol, clearing abnormalities as detected. HIV destroys this patrol force, and cancer rapidly grows in an unguarded environment.
Good news: effective antiretroviral therapy (ART) can restore HIV patients' immune function to a considerable degree, and multiple infection-related cancer risks also drop dramatically accordingly.
5. What you can do now — prevention windows for infection-related cancers
Infection-related cancers are the cancer type with the clearest prevention evidence, and the space for active intervention is substantial.
HPV vaccine prevents approximately ninety percent of cervical cancer, most anal cancer, and oropharyngeal cancer. Both males and females can receive it; the earlier the better. Some guidelines extend recommendations to age forty-five.
Complete hepatitis B vaccination series has a protection rate exceeding ninety-five percent — the most effective means of preventing HBV-related liver cancer. If unsure whether you've been vaccinated, antibody testing is available; those not at protective levels should receive catch-up vaccination.
pylori screening is especially important for those with a family history of stomach cancer or digestive discomfort symptoms. Those testing positive on breath tests who receive eradication treatment can significantly reduce stomach cancer risk.
Hepatitis C now has direct-acting antivirals (DAAs) with a cure rate exceeding ninety-five percent; liver cancer risk significantly drops after cure — one of the largest breakthroughs in infectious disease treatment in recent years.
6. The economics of preventing infection-related cancers: the most cost-effective cancer investment
From a public health economics perspective, preventing infection-related cancers is by far the highest-value-for-money among all cancer prevention measures. In countries that introduced HPV vaccination programs, cervical cancer incidence has already shown significant declines. Australia, one of the world's earliest large-scale HPV vaccine implementers, is expected to achieve cervical cancer elimination (incidence below four per 100,000) by mid-century — not through expensive new therapies, but through a vaccine that's existed for decades combined with systematic vaccination programs and regular screening.
The hepatitis B vaccine story is equally inspiring. Taiwan was one of the earliest regions globally to include hepatitis B vaccine in newborn routine vaccination, starting in 1984. Follow-up data thirty years later shows that the vaccinated generation's hepatocellular carcinoma incidence dropped over seventy percent compared to the unvaccinated previous generation — among the most powerful population evidence for vaccines directly preventing cancer.
For adults over forty who haven't systematically checked their HPV, hepatitis B, hepatitis C, and H. pylori infection status, today is the best time to start. One blood test and one breath test may be the most valuable medical investment you've ever made.
Infection-related cancer prevention is also a family-level matter. Hepatitis B family transmission (mother-to-child, close contact transmission) is a core reason for high HBV prevalence in Asia-Pacific. If a family member has hepatitis B, other members checking hepatitis B antibody status and getting catch-up vaccination not only protects themselves but cuts family transmission chains. H. pylori also transmits among family members — if one member is detected and treated, other members' screening is also worth considering.
Frequently Asked Questions